132 related articles for article (PubMed ID: 24615190)
1. Schedule-dependent interaction between vinblastine and irradiation in experimental sarcoma.
Cemazar M; Dolinsek T; Kosjek T; Markelc B; Sersa G; Kloboves V; Strojan P
Strahlenther Onkol; 2014 Jul; 190(7):661-6. PubMed ID: 24615190
[TBL] [Abstract][Full Text] [Related]
2. Schedule-dependent interaction between vinblastine and cisplatin in Ehrlich ascites tumors in mice.
Cemazar M; Auersperg M; Scancar J; Kirbis IS; Pogacnik A; Sersa G
J Pharmacol Exp Ther; 2002 Jul; 302(1):337-43. PubMed ID: 12065735
[TBL] [Abstract][Full Text] [Related]
3. Interaction between vinblastine and ionizing radiation in the mouse MO4 fibrosarcoma in vivo.
Van Belle S; Fortan L; De Smet M; De Neve W; Van der Elst J; Storme G
Anticancer Res; 1994; 14(3A):1043-8. PubMed ID: 8074448
[TBL] [Abstract][Full Text] [Related]
4. Reduced tumor oxygenation by treatment with vinblastine.
Sersa G; Krzic M; Sentjurc M; Ivanusa T; Beravs K; Cemazar M; Auersperg M; Swartz HM
Cancer Res; 2001 May; 61(10):4266-71. PubMed ID: 11358854
[TBL] [Abstract][Full Text] [Related]
5. Effects of vinblastine on cell membrane fluidity and the growth of SA-1 tumor in mice.
Sersa G; Cemazar M; Sentjurc M; Us-Krasovec M; Kalebić S; Draslar K; Auersperg M
Cancer Lett; 1994 Apr; 79(1):53-60. PubMed ID: 8187053
[TBL] [Abstract][Full Text] [Related]
6. Reduction of vinblastine neurotoxicity in mice utilizing a collagen matrix carrier.
Sutton R; Yu N; Luck E; Brown D; Conley F
Sel Cancer Ther; 1990; 6(1):35-49. PubMed ID: 2188316
[TBL] [Abstract][Full Text] [Related]
7. Prospective randomized trial of interferon alfa-2a plus vinblastine versus vinblastine alone in patients with advanced renal cell cancer.
Pyrhönen S; Salminen E; Ruutu M; Lehtonen T; Nurmi M; Tammela T; Juusela H; Rintala E; Hietanen P; Kellokumpu-Lehtinen PL
J Clin Oncol; 1999 Sep; 17(9):2859-67. PubMed ID: 10561363
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and chemical characterization of 2-methoxy-N(10)-substituted acridones needed to reverse vinblastine resistance in multidrug resistant (MDR) cancer cells.
Krishnegowda G; Thimmaiah P; Hegde R; Dass C; Houghton PJ; Thimmaiah KN
Bioorg Med Chem; 2002 Jul; 10(7):2367-80. PubMed ID: 11983534
[TBL] [Abstract][Full Text] [Related]
9. [Effect of vinblastine nanoparticles on antiproliferation in human glioma cell lines BT325].
Liu YM; Ouyang WQ; Zhang ZQ; Ma SY; Yang BP
Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2365-8. PubMed ID: 19157130
[TBL] [Abstract][Full Text] [Related]
10. Interaction of tubulin with a new fluorescent analogue of vinblastine.
Chatterjee SK; Laffray J; Patel P; Ravindra R; Qin Y; Kuehne ME; Bane SL
Biochemistry; 2002 Nov; 41(47):14010-8. PubMed ID: 12437358
[TBL] [Abstract][Full Text] [Related]
11. Schedule dependency of the combination methotrexate-vinblastine against human urothelial cancer grown in nude mice.
Kyriazis AP; Yagoda A; Kyriazis AA
Anticancer Res; 1989; 9(6):1857-61. PubMed ID: 2627132
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the interaction of TZT-1027, a potent antitumor agent, with tubulin.
Natsume T; Watanabe J; Tamaoki S; Fujio N; Miyasaka K; Kobayashi M
Jpn J Cancer Res; 2000 Jul; 91(7):737-47. PubMed ID: 10920282
[TBL] [Abstract][Full Text] [Related]
13. A model for the action of vinblastine in vivo.
Valeriote FA; Bruce WR; Meeker BE
Biophys J; 1966 Mar; 6(2):145-52. PubMed ID: 5960140
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetics of vinblastine by continuous intravenous infusion.
Lu K; Yap HY; Loo TL
Cancer Res; 1983 Mar; 43(3):1405-8. PubMed ID: 6825110
[TBL] [Abstract][Full Text] [Related]
15. Binding of vinblastine and estramustine to isolated plasma membrane fractions from human prostate and prostatic tumors.
Batra S; Larsson I
Cancer Lett; 1996 Sep; 106(2):217-20. PubMed ID: 8844975
[TBL] [Abstract][Full Text] [Related]
16. Determination of vinblastine in tumour tissue with liquid chromatography-high resolution mass spectrometry.
Kosjek T; Dolinšek T; Gramec D; Heath E; Strojan P; Serša G; Čemažar M
Talanta; 2013 Nov; 116():887-93. PubMed ID: 24148490
[TBL] [Abstract][Full Text] [Related]
17. Region-dependent disappearance of vinblastine in rat small intestine and characterization of its P-glycoprotein-mediated efflux system.
Nakayama A; Saitoh H; Oda M; Takada M; Aungst BJ
Eur J Pharm Sci; 2000 Oct; 11(4):317-24. PubMed ID: 11033075
[TBL] [Abstract][Full Text] [Related]
18. Use of synchronization induced by cyclophosphamide in a methylcholanthrene sarcoma with circadian proliferation to rational sequential chemotherapy.
Focan C; Barbason H; Betz EH
Biomedicine; 1975 Jun; 23(6):230-5. PubMed ID: 1240011
[TBL] [Abstract][Full Text] [Related]
19. [Effects of vinblastine nanoparticles on growth and apoptosis of glioma cell line C6].
Liu Y; Ouyang W; Zhang Z; Yang X; Ma S
Zhongguo Zhong Yao Za Zhi; 2009 Jul; 34(14):1826-30. PubMed ID: 19894518
[TBL] [Abstract][Full Text] [Related]
20. The distribution of [3H]vinblastine in tumor and host tissues of Nb rats bearting a transplantable lymphoma which is highly sensitive to the alkaloid.
Noble RL; Gout PW; Wijcik LL; Hebden HF; Beer CT
Cancer Res; 1977 May; 37(5):1455-60. PubMed ID: 856464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
